It is established by a Chinese scientist, Dr. Charlene Liao, a cutting-edge company that innovates cancer immunotherapy for new targets.
Location: United States, California, Palo Alto
Employees: 11-50
Total raised: $244M
Founded date: 2016
Investors 11
Show more
Funding Rounds 4
| Date | Series | Amount | Investors |
| 06.01.2023 | Series B | $131M | - |
| 30.03.2021 | Series A | $73M | - |
| 18.09.2018 | Series B | $33M | - |
| 06.09.2016 | Series A | $7M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 30.03.2023 | Smart Immune receives €2.5m grant and €15m equity investment... | - | globenewsw... |
| 06.01.2023 | Immune-Onc Therapeutics Closes $131M Series B | PALO ALTO, CA, Immune-Onc Therapeutics, a private, clinical-stage cancer immunotherapy company, ha... | vcnewsdail... |
| 14.04.2021 | Immune therapy startup scores $189M | Flagship Pioneering-backed Repertoire Immune Medicines has raised a $189 million Series B from inves... | pitchbook.... |
| 30.03.2021 | Immune-Onc Therapeutics Announces $73 Million in Series B1 a... | Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage cancer immunotherapy company developi... | marketscre... |
| 30.03.2021 | Immune-Onc Therapeutics Announces $73 Million in Series B1 a... | - | 3ebiovc.co... |
| 18.03.2021 | Boston Immune Technologies and Therapeutics Raises $10M Seri... | Boston Immune Technologies and Therapeutics, Inc. (BITT), a Boston, MA based developer of novel TNF ... | finsmes.co... |
| 17.03.2021 | Boston Immune Technologies and Therapeutics Raises $10M Seri... | BOSTON--(BUSINESS WIRE)--Mar 17, 2021-- Boston Immune Technologies and Therapeutics, Inc. (BITT), a... | oaoa.com/n... |
| 19.09.2018 | Immune-Onc Therapeutics Raises More Than $33M in Series B Fu... | Immune-Onc Therapeutics, Inc., a Palo Alto, Calif.-based cancer immunotherapy company dedicated to t... | finsmes.co... |
| 18.09.2018 | Immune-Onc raises $33M in Series B funding round for immunot... | The firm announced in September 2016 the closing of a $7 million Series A funding round, in which ma... | medcitynew... |
| 17.11.2016 | Immune Pharmaceuticals Secures Up to $11 Million in New Fina... | Immune Pharmaceuticals (NASDAQ:IMNP) (Immune) announced today that it has secured up to $11 million ... | citybizlis... |
Show more